Advertisement

HSKA

Heska Corporation

Healthcare

Set alert

Price alert · HSKA

All alert types
119.99 0.00 0.00%
As of Jun 12, 2023
119.99 Day range 119.99

52-week range unavailable

Open
119.96
Prev close
119.99
Mkt cap
1.31B
Vol
330.89K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
119.99
High
119.99
Forward P/E
799.93
Beta
1.60
Short ratio
5.41
Inst. own
87.54%
Dividend
0.00
Ex-div date
Sep 25, 2012
Earnings
May 5, 2023
50-d avg
117.55
200-d avg
87.11
1y target
130.00

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for HSKA has not been loaded yet. Try again in a moment.

Key statistics

Market cap
1.31B
Enterprise value
1.29B
Trailing P/E
0.00
Forward P/E
799.93
PEG ratio
-5.71
Price / sales
5.14
Price / book
3.14
EPS (TTM)
-1.92
Beta
1.60
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-7.86%
Revenue (TTM)
254.89M
Revenue growth
-3.70%
Free cash flow
-5.78M
Total cash
125.21M
Total debt
109.92M
Return on equity
-4.73%
Shares outstanding
10.91M
Short % of float
16.75%
50-day average
117.55
200-day average
87.11

Analyst view

Consensus: buy

Buy
Price target (mean) 130.00 +8.3% upside
Target (low)
120.00
Target (mean)
130.00
Target (high)
150.00
Ratings (0m) 8 4 buy · 4 hold · 0 sell
  • Strong buy1
  • Buy3
  • Hold4
  • Sell0
  • Strong sell0

Next earnings

May 5, 2023

Expected May 5, 2023. Consensus EPS estimate -0.22.

Earnings history

Financials — quick view

All financials
HSKA Revenue — quarterly 62.38M
2019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 2023
HSKA Net income — quarterly -10.13M
2019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 2023
HSKA EPS — quarterly -0.97
2019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 2023

Earnings

HSKA recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
May 5, 2023Mar 1, 20230.32———
Feb 28, 2023Dec 1, 20220.38———
Nov 8, 2022Sep 1, 20220.45———
Aug 8, 2022Jun 1, 20220.37———
May 9, 2022Mar 1, 20220.41———
Feb 28, 2022Dec 1, 20210.32———

Upgrades / downgrades

HSKA analyst upgrades and downgrades
DateFirmActionFromTo
Apr 4, 2023Morgan Stanleymain—Equal-Weight
Jan 6, 2023Morgan StanleydownEqual-WeightUnderweight
Nov 14, 2022Piper Sandlermain—Overweight
Nov 9, 2022Morgan Stanleymain—Equal-Weight
Nov 9, 2022Alliance Global Partnersmain—Buy
Oct 17, 2022JP Morganmain—Overweight

About Heska Corporation

Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
heska.com

News

Your note

Sign in to keep a note on HSKA — it syncs with the Stock Master app.

Insider holders

HSKA insider holders
InsiderRelationLatest transactionDateShares held
ANTIN ROBERT LDirectorStock Award(Grant)May 3, 20222,189
BAKER ELEANOR FOfficerStock Award(Grant)Jun 12, 20230
EYL STEVEN MOfficerStock Award(Grant)Mar 23, 202326,904
FURLONG MARK FDirectorStock Award(Grant)May 3, 20224,726
GRASSMAN CATHERINE IChief Financial OfficerStock Award(Grant)May 31, 202314,261
LARSON SHARON J.DirectorStock Award(Grant)May 3, 20228,608

Institution ownership

HSKA institution ownership
Holder% heldSharesValueReported
Blackrock Inc.17.13%1,869,493224.32MMar 30, 2023
Nine Ten Capital Management LLC8.03%876,008105.11MMar 30, 2023
Fred Alger Management, LLC7.59%828,86899.46MMar 30, 2023
Vanguard Group, Inc. (The)6.70%730,93987.71MMar 30, 2023
Ameriprise Financial, Inc.5.29%577,37569.28MMar 30, 2023
State Street Corporation3.98%434,46452.13MMar 30, 2023

Fund ownership

HSKA fund ownership
Holder% heldSharesValueReported
iShares Core S&P Smallcap ETF7.07%768,98092.27MFeb 27, 2023
Alger Small Cap Focus Fund6.56%713,59385.62MJan 30, 2023
Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I3.45%375,20845.02MFeb 27, 2023
Vanguard Total Stock Market Index Fund2.85%309,78437.17MDec 30, 2022
iShares Russell 2000 ETF1.94%211,31825.36MFeb 27, 2023
iShares S&P Smallcap 600 Value ETF1.68%182,15921.86MFeb 27, 2023
Advertisement